Lidong Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lidong Hu has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Feng Huang
Department of Cardiology & Guangxi Key Laboratory Base of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention & Guangxi Clinical Research Center for Cardio-Cerebrovascular Diseases, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
9 shared publications - Jian Zhu
Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital, Beijing, China
9 shared publications - Xiaojian Ji
Department of Rheumatology, Chinese PLA General Hospital, Beijing, China
9 shared publications - Yiwen Wang
Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital, Beijing, China
8 shared publications - Xingkang Liu
Department of Rehabilitation Medicine, The Second Medical Center, Chinese PLA General Hospital, Beijing, China
7 shared publications - Jianglin Zhang
Department of Rheumatology and Immunology The First Medical Center of Chinese PLA General Hospital 28 Fuxing Road, Haidian District Beijing 100853 China 301hospital.com.cn
4 shared publications
Latest Publications
- Open Access
- 22 January 2026
- Published by Springer Nature in npj Digital Medicine
- Vol. 9 (1)
Early diagnosis of axial spondyloarthritis in primary care using multi-agent systems
Axial spondyloarthritis (axSpA) is an inflammatory disease marked by chronic low back pain, with a global average diagnostic delay of 6.7 years. Early diagnosis is crucial for improving prognosis and reducing disability rates, yet primary care physicians (PCPs) may find it challenging to ensure timely recognition and referrals. This study developed and validated Spondyloarthritis Agents (SpAgents), an early diagnostic system based on a multi-agent framework integrating large language models (LLMs) and imaging models. The SpAgents framework includes PlannerAgent, DataAgent, ToolAgent, and DoctorAgent, supported by long-term memory for dynamic knowledge updates. We enrolled 596 patients, dividing 545 from one hospital into a training dataset (n = 359) and a validation dataset (n = 186), along with an independent cohort of 51 patients from five additional hospitals for testing. SpAgents demonstrated strong diagnostic performance, achieving sensitivity of 0.8615 and specificity of 0.8000 during validation, and 0.9375 and 0.7368 during testing. SpAgents exhibited significantly higher sensitivity (0.9400) and accuracy (0.8600) than both PCPs and junior rheumatologists, with overall performance equivalent to that of senior rheumatologists. Under SpAgents-assisted diagnosis, both PCPs and junior rheumatologists showed marked improvements in sensitivity and accuracy. SpAgents effectively enhance early axSpA identification among PCPs, offering an innovative solution to reduce diagnostic delays.
- 22 January 2026
- Published by Springer Nature in npj Digital Medicine
- Vol. 9 (1)
Open AccessEarly diagnosis of axial spondyloarthritis in primary care using multi-agent systems
Axial spondyloarthritis (axSpA) is an inflammatory disease marked by chronic low back pain, with a global average diagnostic delay of 6.7 years. Early diagnosis is crucial for improving prognosis and reducing disability rates, yet primary care physicians (PCPs) may find it challenging to ensure timely recognition and referrals. This study developed and validated Spondyloarthritis Agents (SpAgents), an early diagnostic system based on a multi-agent framework integrating large language models (LLMs) and imaging models. The SpAgents framework includes PlannerAgent, DataAgent, ToolAgent, and DoctorAgent, supported by long-term memory for dynamic knowledge updates. We enrolled 596 patients, dividing 545 from one hospital into a training dataset (n = 359) and a validation dataset (n = 186), along with an independent cohort of 51 patients from five additional hospitals for testing. SpAgents demonstrated strong diagnostic performance, achieving sensitivity of 0.8615 and specificity of 0.8000 during validation, and 0.9375 and 0.7368 during testing. SpAgents exhibited significantly higher sensitivity (0.9400) and accuracy (0.8600) than both PCPs and junior rheumatologists, with overall performance equivalent to that of senior rheumatologists. Under SpAgents-assisted diagnosis, both PCPs and junior rheumatologists showed marked improvements in sensitivity and accuracy. SpAgents effectively enhance early axSpA identification among PCPs, offering an innovative solution to reduce diagnostic delays.
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Immunology Research
- Vol. 2026 (1)
High‐Titer Antinuclear Antibody Defines a Distinct IgG4‐Related Disease Subset With Predilection for Lung and Kidney Involvement
Objective: This study investigated whether antinuclear antibody (ANA) positivity identifies a distinct clinical phenotype in IgG4‐related disease (IgG4‐RD), characterized by specific organ involvement patterns. Methods: We conducted a cohort study of patients diagnosed with IgG4‐RD (2016–2024). Based on indirect immunofluorescence (IIF) results, patients were categorized as ANA‐negative (titer ≤ 1:100) or ANA‐positive, with the latter further stratified by titer: group 1 (moderate titer, 1:320) and group 2 (high titer, ≥1:1000). We comprehensively compared demographics, organ involvement, and laboratory profiles across groups. Multivariable logistic regression was used to quantify associations. Results: Among 278 patients, 38 (13.7%) were ANA‐positive ( n = 19 per titer‐based subgroup). ANA patterns differed: granular in group 1 versus homogeneous/granular homogeneous in group 2. Only patients in group 2 (high‐titer ANA) demonstrated a significantly elevated risk of lung and kidney initial onset and involvement compared to ANA‐negative patients. This group also exhibited marked hypocomplementemia. The adjusted odds ratios for lung and kidney involvement in group 2 were 10.18 (95% CI: 3.590–28.876) and 4.42 (95% CI: 1.605–12.151), respectively. No such associations were found in group 1. Conclusion: IgG4‐RD combined with high‐titer ANA (≥1:1000), mainly presenting as homogeneous type or homogeneous granular type, characterized by a heightened propensity for lung and kidney, initial onset and involvement, and hypocomplementemia. Routine ANA testing and careful assessment of pulmonary and renal systems are warranted in these patients.
- 1 January 2026
- Published by Wiley in Journal of Immunology Research
- Vol. 2026 (1)
Open AccessHigh‐Titer Antinuclear Antibody Defines a Distinct IgG4‐Related Disease Subset With Predilection for Lung and Kidney Involvement
Objective: This study investigated whether antinuclear antibody (ANA) positivity identifies a distinct clinical phenotype in IgG4‐related disease (IgG4‐RD), characterized by specific organ involvement patterns. Methods: We conducted a cohort study of patients diagnosed with IgG4‐RD (2016–2024). Based on indirect immunofluorescence (IIF) results, patients were categorized as ANA‐negative (titer ≤ 1:100) or ANA‐positive, with the latter further stratified by titer: group 1 (moderate titer, 1:320) and group 2 (high titer, ≥1:1000). We comprehensively compared demographics, organ involvement, and laboratory profiles across groups. Multivariable logistic regression was used to quantify associations. Results: Among 278 patients, 38 (13.7%) were ANA‐positive ( n = 19 per titer‐based subgroup). ANA patterns differed: granular in group 1 versus homogeneous/granular homogeneous in group 2. Only patients in group 2 (high‐titer ANA) demonstrated a significantly elevated risk of lung and kidney initial onset and involvement compared to ANA‐negative patients. This group also exhibited marked hypocomplementemia. The adjusted odds ratios for lung and kidney involvement in group 2 were 10.18 (95% CI: 3.590–28.876) and 4.42 (95% CI: 1.605–12.151), respectively. No such associations were found in group 1. Conclusion: IgG4‐RD combined with high‐titer ANA (≥1:1000), mainly presenting as homogeneous type or homogeneous granular type, characterized by a heightened propensity for lung and kidney, initial onset and involvement, and hypocomplementemia. Routine ANA testing and careful assessment of pulmonary and renal systems are warranted in these patients.
- Open Access
- 7 July 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e67556
Effects of a Digital Functional Exercise Program on the Disease Activities and Physical Capabilities of Patients With Ankylosing Spondylitis: Protocol for a Randomized Controlled Trial
Background: Ankylosing spondylitis (AS), a chronic inflammatory disease, causes spinal stiffness, functional impairment, and reduced quality of life. While exercise is critical for managing AS, traditional home-based programs lack real-time supervision to ensure movement quality and adherence. Emerging digital tools like inertial sensors may address this gap, but their clinical impact remains unproven. Objective: This study aims to evaluate the feasibility and efficacy of a Digital Functional Exercise Program (DFEP) using wearable sensors and real-time feedback for patients with AS. Methods: This single-blind randomized controlled trial (ChiCTR2300068327) enrolled 80 adults with AS from the Chinese People’s Liberation Army (PLA) General Hospital. Participants were randomized 1:1 to: DFEP Group: 24-week sensor-guided exercises via the Healbone Mini Program (Jiakangzhongzhi, Co), with real-time feedback and remote physiotherapist oversight. Control Group: standard home-based exercises with written instructions. The primary outcome is the change in Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) at 24 weeks. Secondary outcomes include Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Metrology Index (BASMI), Assessment of Spondyloarthritis International Society Health Index (ASAS HI), 36-Item Short Form Survey (SF-36), pain visual analog scale, Five-Times-Sit-to-Stand, 4-meter walk test, Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), and adherence. Analyses will follow an intention-to-treat approach with the Last Observation Carried Forward for missing data; continuous variables will be compared with t tests or ANOVA, and categorical variables with chi-square tests, using a 2-sided =.05. Results: We have screened 216 outpatients who may be eligible subjects, among them 126 outpatients who initially met the inclusion criteria. After evaluating clinicians performed face-to-face assessments, 23 lacked a stable medication regimen, 5 presented with severe cervical vertebral bridges, 3 reported regular structured exercise, 2 could not be reached after prescreening, 10 had significant cardiovascular disease, and 3 declined participation due to time constraints. Ultimately, 80 eligible participants were enrolled, with 36 randomly allocated to the intervention group and 44 to the control group. Recruitment (February 2023-March 2024) and follow-up (concluding September 2024) are complete. Data analysis (November 2024) and result dissemination (April 2025) are pending. Conclusions: This trial is the first to test a fully digital, sensor-based exercise program for AS. If effective, DFEP could offer a scalable, cost-effective solution for home rehabilitation in AS and related conditions. Trial Registration: Chinese Clinical Trial Registry ChiCTR2300068327; https://www.chictr.org.cn/showproj.html?proj=190897 International Registered Report Identifier (IRRID): DERR1-10.2196/67556
- 7 July 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e67556
Open AccessEffects of a Digital Functional Exercise Program on the Disease Activities and Physical Capabilities of Patients With Ankylosing Spondylitis: Protocol for a Randomized Controlled Trial
Background: Ankylosing spondylitis (AS), a chronic inflammatory disease, causes spinal stiffness, functional impairment, and reduced quality of life. While exercise is critical for managing AS, traditional home-based programs lack real-time supervision to ensure movement quality and adherence. Emerging digital tools like inertial sensors may address this gap, but their clinical impact remains unproven. Objective: This study aims to evaluate the feasibility and efficacy of a Digital Functional Exercise Program (DFEP) using wearable sensors and real-time feedback for patients with AS. Methods: This single-blind randomized controlled trial (ChiCTR2300068327) enrolled 80 adults with AS from the Chinese People’s Liberation Army (PLA) General Hospital. Participants were randomized 1:1 to: DFEP Group: 24-week sensor-guided exercises via the Healbone Mini Program (Jiakangzhongzhi, Co), with real-time feedback and remote physiotherapist oversight. Control Group: standard home-based exercises with written instructions. The primary outcome is the change in Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) at 24 weeks. Secondary outcomes include Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Metrology Index (BASMI), Assessment of Spondyloarthritis International Society Health Index (ASAS HI), 36-Item Short Form Survey (SF-36), pain visual analog scale, Five-Times-Sit-to-Stand, 4-meter walk test, Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), and adherence. Analyses will follow an intention-to-treat approach with the Last Observation Carried Forward for missing data; continuous variables will be compared with t tests or ANOVA, and categorical variables with chi-square tests, using a 2-sided =.05. Results: We have screened 216 outpatients who may be eligible subjects, among them 126 outpatients who initially met the inclusion criteria. After evaluating clinicians performed face-to-face assessments, 23 lacked a stable medication regimen, 5 presented with severe cervical vertebral bridges, 3 reported regular structured exercise, 2 could not be reached after prescreening, 10 had significant cardiovascular disease, and 3 declined participation due to time constraints. Ultimately, 80 eligible participants were enrolled, with 36 randomly allocated to the intervention group and 44 to the control group. Recruitment (February 2023-March 2024) and follow-up (concluding September 2024) are complete. Data analysis (November 2024) and result dissemination (April 2025) are pending. Conclusions: This trial is the first to test a fully digital, sensor-based exercise program for AS. If effective, DFEP could offer a scalable, cost-effective solution for home rehabilitation in AS and related conditions. Trial Registration: Chinese Clinical Trial Registry ChiCTR2300068327; https://www.chictr.org.cn/showproj.html?proj=190897 International Registered Report Identifier (IRRID): DERR1-10.2196/67556
- Open Access
Clinical and genetic determinants of worse sexual experience in male patients with radiographic axial spondyloarthritis: a multimodal study
Objective: The expression and experience of sexuality is a key part of an individual’s self-identity, yet it is often overlooked in clinical settings. This study aims to evaluate the impact of radiographic axial spondyloarthritis (r-axSpA) on sexual experience in male patients, identify contributing factors and explore the potential causal relationship between r-axSpA and erectile dysfunction (ED). Methods: We assessed the sexual experience of 113 male patients with r-axSpA and 73 healthy people using the Sexual Experience Questionnaire in the cross-sectional study. Linear regression analysis was used to explore the contributions of clinical factors to worse sexual experience. A two-sample Mendelian randomisation (MR) design was conducted to examine the potential causal association of r-axSpA with the risk of ED. Results: There was a significant difference in the total sexual experience score between patients with r-axSpA and healthy controls (41.81±8.71 vs 50.23±8.82, p<0.001). Patients with r-axSpA had a worse score in all dimensions of sexual experience, including erectile function, individual satisfaction and couple satisfaction, compared with healthy individuals. In the regression model adjusted for age, disease duration and body mass index, disease activity (Bath Ankylosing Spondylitis Disease Activity Index), physical function (Bath Ankylosing Spondylitis Functional Index), mobility (Bath Ankylosing Spondylitis Metrology Index, chest expansion and finger-floor distance), health index (Assessment of SpondyloArthritis international Society Health Index), sleep quality (Pittsburgh Sleep Quality Index) and psychological status (Hospital Anxiety and Depression Scale (HADS), HADS-Anxiety and HADS-Depression) were significant determinants of sexual experience. The two-sample MR analysis demonstrated no causal effect of r-axSpA on the risk of ED (OR: 0.973; 95% CI: 0.824 to 1.149; p=0.749) based on the inverse variance weighted method. Sensitivity analyses supported the result, with no evidence of directional pleiotropy. Conclusions: Worse sexual experience was associated with increased disease activity, reduced mobility, lower health index, poor sleep quality and psychological status. Genetic-level evidence indicated no direct causal relationship between r-axSpA and ED. Therefore, actively assessing disease-related suffering and developing new management strategies are essential for improving sexual experience in patients with r-axSpA.
Open AccessClinical and genetic determinants of worse sexual experience in male patients with radiographic axial spondyloarthritis: a multimodal study
Objective: The expression and experience of sexuality is a key part of an individual’s self-identity, yet it is often overlooked in clinical settings. This study aims to evaluate the impact of radiographic axial spondyloarthritis (r-axSpA) on sexual experience in male patients, identify contributing factors and explore the potential causal relationship between r-axSpA and erectile dysfunction (ED). Methods: We assessed the sexual experience of 113 male patients with r-axSpA and 73 healthy people using the Sexual Experience Questionnaire in the cross-sectional study. Linear regression analysis was used to explore the contributions of clinical factors to worse sexual experience. A two-sample Mendelian randomisation (MR) design was conducted to examine the potential causal association of r-axSpA with the risk of ED. Results: There was a significant difference in the total sexual experience score between patients with r-axSpA and healthy controls (41.81±8.71 vs 50.23±8.82, p<0.001). Patients with r-axSpA had a worse score in all dimensions of sexual experience, including erectile function, individual satisfaction and couple satisfaction, compared with healthy individuals. In the regression model adjusted for age, disease duration and body mass index, disease activity (Bath Ankylosing Spondylitis Disease Activity Index), physical function (Bath Ankylosing Spondylitis Functional Index), mobility (Bath Ankylosing Spondylitis Metrology Index, chest expansion and finger-floor distance), health index (Assessment of SpondyloArthritis international Society Health Index), sleep quality (Pittsburgh Sleep Quality Index) and psychological status (Hospital Anxiety and Depression Scale (HADS), HADS-Anxiety and HADS-Depression) were significant determinants of sexual experience. The two-sample MR analysis demonstrated no causal effect of r-axSpA on the risk of ED (OR: 0.973; 95% CI: 0.824 to 1.149; p=0.749) based on the inverse variance weighted method. Sensitivity analyses supported the result, with no evidence of directional pleiotropy. Conclusions: Worse sexual experience was associated with increased disease activity, reduced mobility, lower health index, poor sleep quality and psychological status. Genetic-level evidence indicated no direct causal relationship between r-axSpA and ED. Therefore, actively assessing disease-related suffering and developing new management strategies are essential for improving sexual experience in patients with r-axSpA.
- Open Access
- 20 October 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Effects of a Digital Functional Exercise Program on the Disease Activities and Physical Capabilities of Patients With Ankylosing Spondylitis: Protocol for a Randomized Controlled Trial (Preprint)
BACKGROUND Ankylosing spondylitis (AS), a chronic inflammatory disease, causes spinal stiffness, functional impairment, and reduced quality of life. While exercise is critical for managing AS, traditional home-based programs lack real-time supervision to ensure movement quality and adherence. Emerging digital tools like inertial sensors may address this gap, but their clinical impact remains unproven. OBJECTIVE This study aims to evaluate the feasibility and efficacy of a Digital Functional Exercise Program (DFEP) using wearable sensors and real-time feedback for patients with AS. METHODS This single-blind randomized controlled trial (ChiCTR2300068327) enrolled 80 adults with AS from the Chinese People’s Liberation Army (PLA) General Hospital. Participants were randomized 1:1 to: DFEP Group: 24-week sensor-guided exercises via the Healbone Mini Program (Jiakangzhongzhi, Co), with real-time feedback and remote physiotherapist oversight. Control Group: standard home-based exercises with written instructions. The primary outcome is the change in Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) at 24 weeks. Secondary outcomes include Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Metrology Index (BASMI), Assessment of Spondyloarthritis International Society Health Index (ASAS HI), 36-Item Short Form Survey (SF-36), pain visual analog scale, Five-Times-Sit-to-Stand, 4-meter walk test, Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), and adherence. Analyses will follow an intention-to-treat approach with the Last Observation Carried Forward for missing data; continuous variables will be compared with t tests or ANOVA, and categorical variables with chi-square tests, using a 2-sided =.05. RESULTS We have screened 216 outpatients who may be eligible subjects, among them 126 outpatients who initially met the inclusion criteria. After evaluating clinicians performed face-to-face assessments, 23 lacked a stable medication regimen, 5 presented with severe cervical vertebral bridges, 3 reported regular structured exercise, 2 could not be reached after prescreening, 10 had significant cardiovascular disease, and 3 declined participation due to time constraints. Ultimately, 80 eligible participants were enrolled, with 36 randomly allocated to the intervention group and 44 to the control group. Recruitment (February 2023-March 2024) and follow-up (concluding September 2024) are complete. Data analysis (November 2024) and result dissemination (April 2025) are pending. CONCLUSIONS This trial is the first to test a fully digital, sensor-based exercise program for AS. If effective, DFEP could offer a scalable, cost-effective solution for home rehabilitation in AS and related conditions. CLINICALTRIAL Chinese Clinical Trial Registry ChiCTR2300068327; https://www.chictr.org.cn/showproj.html?proj=190897 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/67556
- 20 October 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEffects of a Digital Functional Exercise Program on the Disease Activities and Physical Capabilities of Patients With Ankylosing Spondylitis: Protocol for a Randomized Controlled Trial (Preprint)
BACKGROUND Ankylosing spondylitis (AS), a chronic inflammatory disease, causes spinal stiffness, functional impairment, and reduced quality of life. While exercise is critical for managing AS, traditional home-based programs lack real-time supervision to ensure movement quality and adherence. Emerging digital tools like inertial sensors may address this gap, but their clinical impact remains unproven. OBJECTIVE This study aims to evaluate the feasibility and efficacy of a Digital Functional Exercise Program (DFEP) using wearable sensors and real-time feedback for patients with AS. METHODS This single-blind randomized controlled trial (ChiCTR2300068327) enrolled 80 adults with AS from the Chinese People’s Liberation Army (PLA) General Hospital. Participants were randomized 1:1 to: DFEP Group: 24-week sensor-guided exercises via the Healbone Mini Program (Jiakangzhongzhi, Co), with real-time feedback and remote physiotherapist oversight. Control Group: standard home-based exercises with written instructions. The primary outcome is the change in Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) at 24 weeks. Secondary outcomes include Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Metrology Index (BASMI), Assessment of Spondyloarthritis International Society Health Index (ASAS HI), 36-Item Short Form Survey (SF-36), pain visual analog scale, Five-Times-Sit-to-Stand, 4-meter walk test, Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), and adherence. Analyses will follow an intention-to-treat approach with the Last Observation Carried Forward for missing data; continuous variables will be compared with t tests or ANOVA, and categorical variables with chi-square tests, using a 2-sided =.05. RESULTS We have screened 216 outpatients who may be eligible subjects, among them 126 outpatients who initially met the inclusion criteria. After evaluating clinicians performed face-to-face assessments, 23 lacked a stable medication regimen, 5 presented with severe cervical vertebral bridges, 3 reported regular structured exercise, 2 could not be reached after prescreening, 10 had significant cardiovascular disease, and 3 declined participation due to time constraints. Ultimately, 80 eligible participants were enrolled, with 36 randomly allocated to the intervention group and 44 to the control group. Recruitment (February 2023-March 2024) and follow-up (concluding September 2024) are complete. Data analysis (November 2024) and result dissemination (April 2025) are pending. CONCLUSIONS This trial is the first to test a fully digital, sensor-based exercise program for AS. If effective, DFEP could offer a scalable, cost-effective solution for home rehabilitation in AS and related conditions. CLINICALTRIAL Chinese Clinical Trial Registry ChiCTR2300068327; https://www.chictr.org.cn/showproj.html?proj=190897 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/67556
- Open Access
- 17 February 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (4) , 1621
Dietary Fiber Intake Influences Changes in Ankylosing Spondylitis Disease Status
The objectives of this study were to characterize dietary fiber (DF) intake in patients with ankylosing spondylitis (AS), to assess whether DF intake affects disease activity in AS, and to investigate the effect of DF intake on disease activity in AS in the context of functional bowel disease (FBD) symptoms. We recruited 165 patients with AS and divided them into two groups according to whether they had a high DF intake > 25 g/d to investigate the characteristics of people with high DF intake. Some 72 of the 165 AS patients (43%) met the criteria for high DF intake, which was more common in patients with negative FBD symptoms (68%). Data analysis revealed that DF intake was negatively associated with AS disease activity and did not differ statistically significantly from FBD symptoms. Multivariate adjusted models were used to explore the effect of DF intake on AS disease activity. ASDAS-CRP and BASDAI were stable and negatively correlated across models in both groups with and without FBD symptoms. Thus, DF intake positively affected disease activity in patients with AS. ASDAS-CRP and BASDAI were negatively correlated with DF intake.
- 17 February 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (4) , 1621
Open AccessDietary Fiber Intake Influences Changes in Ankylosing Spondylitis Disease Status
The objectives of this study were to characterize dietary fiber (DF) intake in patients with ankylosing spondylitis (AS), to assess whether DF intake affects disease activity in AS, and to investigate the effect of DF intake on disease activity in AS in the context of functional bowel disease (FBD) symptoms. We recruited 165 patients with AS and divided them into two groups according to whether they had a high DF intake > 25 g/d to investigate the characteristics of people with high DF intake. Some 72 of the 165 AS patients (43%) met the criteria for high DF intake, which was more common in patients with negative FBD symptoms (68%). Data analysis revealed that DF intake was negatively associated with AS disease activity and did not differ statistically significantly from FBD symptoms. Multivariate adjusted models were used to explore the effect of DF intake on AS disease activity. ASDAS-CRP and BASDAI were stable and negatively correlated across models in both groups with and without FBD symptoms. Thus, DF intake positively affected disease activity in patients with AS. ASDAS-CRP and BASDAI were negatively correlated with DF intake.
- 4 December 2022
- Published by Springer Nature in Rheumatology International
- Vol. 43 (1) , 173-182
Bibliometric analysis of publications on enthesitis in spondyloarthritis in 2012–2021 based on web of science core collection databases
Enthesitis, a characteristic of spondyloarthritis, has been paid considerable attention by researchers, and numerous enthesitis-related studies have been published in recent years. However, no study has been conducted to analyze enthesitis-related researches with bibliometric methods. This study aimed to provide a broad understanding of enthesitis-related researches and explore the direction of hot topics and future research trends from a bibliometric perspective. The global literatures on enthesitis published from 2012 to 2021 were scanned in the Web of Science Core Collection databases. Visualization and bibliometric analyses were generated by an online bibliometric platform and VOSviewer software to explore the hot topics and research trends. A total of 1,181 documents were included in this study. Publications were mainly from these countries in North America and Western Europe. Among these countries, the United States was the leading country with the maximum publication counts (210), highest h-index (47), and largest collaboration network as of June 29, 2022. The most influential journal and powerful author were Journal of Rheumatology and Professor Mease PJ, respectively. Co-occurrence analysis of keywords identified that “axial spondyloarthritis”, “interleukin 23”, and “secukinumab” might be the future hotspots. More and more attention had been paid to enthesitis in the past 10 years. Present studies focused on the effect of inflammatory cytokines involved in the pathogenesis and the development of antibodies against these factors. These studies played a key role in understanding the research direction and subsequent management of enthesitis, and helped researchers extract hidden valuable information for further study.
- 4 December 2022
- Published by Springer Nature in Rheumatology International
- Vol. 43 (1) , 173-182
Bibliometric analysis of publications on enthesitis in spondyloarthritis in 2012–2021 based on web of science core collection databases
Enthesitis, a characteristic of spondyloarthritis, has been paid considerable attention by researchers, and numerous enthesitis-related studies have been published in recent years. However, no study has been conducted to analyze enthesitis-related researches with bibliometric methods. This study aimed to provide a broad understanding of enthesitis-related researches and explore the direction of hot topics and future research trends from a bibliometric perspective. The global literatures on enthesitis published from 2012 to 2021 were scanned in the Web of Science Core Collection databases. Visualization and bibliometric analyses were generated by an online bibliometric platform and VOSviewer software to explore the hot topics and research trends. A total of 1,181 documents were included in this study. Publications were mainly from these countries in North America and Western Europe. Among these countries, the United States was the leading country with the maximum publication counts (210), highest h-index (47), and largest collaboration network as of June 29, 2022. The most influential journal and powerful author were Journal of Rheumatology and Professor Mease PJ, respectively. Co-occurrence analysis of keywords identified that “axial spondyloarthritis”, “interleukin 23”, and “secukinumab” might be the future hotspots. More and more attention had been paid to enthesitis in the past 10 years. Present studies focused on the effect of inflammatory cytokines involved in the pathogenesis and the development of antibodies against these factors. These studies played a key role in understanding the research direction and subsequent management of enthesitis, and helped researchers extract hidden valuable information for further study.
- Open Access
- 30 April 2022
- Published by Hindawi Limited in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-12
Clinical Efficacy of Acupuncture for the Treatment of Rheumatoid Arthritis: Meta-Analysis of Randomized Clinical Trials
Objective. Acupuncture has been used by rehabilitation specialists as an adjunctive treatment for the symptomatic treatment of rheumatoid arthritis (RA). This meta-analysis aims to evaluate the efficacy of acupuncture in treating patients with RA. Methods. A comprehensive search was conducted in CBM, CNKI, PubMed, CENTRAL, Web of Science, and Embase from their inception up to March 2022. All randomized controlled trials (RCTs) without the language restriction, concerning the patients with RA treated with acupuncture, were included. Two reviewers independently assessed the risk of bias with the Cochrane Risk of Bias Assessment tool. Weight mean difference (MD) and 95% CI were calculated, and data were pooled with random effects model. Results. A total of eleven RCTs involving 796 patients with RA met the established inclusion criteria. This systematic review indicated the efficacy of acupuncture as an adjunctive treatment for patients with RA. Invasive acupuncture could reduce significantly in pain (MD = -1.00, 95% CI: −1.96 to −0.05, ), health assessment questionnaire (HAQ, MD = −0.20, 95% CI: −0.30 to −0.11, ), physician global assessment (PhGA, MD = −0.98, 95% CI: −1.23 to −0.72, ), tender joint count (TJC, MD = −1.24, 95% CI: −2.11 to −0.37, ), C-reactive protein (CRP, MD = −1.81, 95% CI: −3.32 to −0.29, ), and erythrocyte sedimentation rate (ESR, MD = −3.03, 95% CI: −5.80 to −0.26, ), while compared to control group. Laser acupuncture could reduce HAQ (MD = −0.15, 95% CI: −0.28 to −0.01, ), the RA quality of life questionnaire (RAQoL, MD = −2.32, 95% CI: −4.40 to −0.25, ), CRP (MD = −35.24, 95% CI: −36.49 to −33.99, ), and interleukin-6 (IL-6, MD = −29.63, 95% CI: −49.34 to −9.92, ), while compared to control group. No adverse events associated with acupuncture were reported. Conclusion. Available evidence suggests that acupuncture is beneficial for relieving pain and ameliorating quality of life and health index in patients with RA; thereby, it should be available as an adjunctive nonpharmacological treatment in rehabilitation programmes.
- 30 April 2022
- Published by Hindawi Limited in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-12
Open AccessClinical Efficacy of Acupuncture for the Treatment of Rheumatoid Arthritis: Meta-Analysis of Randomized Clinical Trials
Objective. Acupuncture has been used by rehabilitation specialists as an adjunctive treatment for the symptomatic treatment of rheumatoid arthritis (RA). This meta-analysis aims to evaluate the efficacy of acupuncture in treating patients with RA. Methods. A comprehensive search was conducted in CBM, CNKI, PubMed, CENTRAL, Web of Science, and Embase from their inception up to March 2022. All randomized controlled trials (RCTs) without the language restriction, concerning the patients with RA treated with acupuncture, were included. Two reviewers independently assessed the risk of bias with the Cochrane Risk of Bias Assessment tool. Weight mean difference (MD) and 95% CI were calculated, and data were pooled with random effects model. Results. A total of eleven RCTs involving 796 patients with RA met the established inclusion criteria. This systematic review indicated the efficacy of acupuncture as an adjunctive treatment for patients with RA. Invasive acupuncture could reduce significantly in pain (MD = -1.00, 95% CI: −1.96 to −0.05, ), health assessment questionnaire (HAQ, MD = −0.20, 95% CI: −0.30 to −0.11, ), physician global assessment (PhGA, MD = −0.98, 95% CI: −1.23 to −0.72, ), tender joint count (TJC, MD = −1.24, 95% CI: −2.11 to −0.37, ), C-reactive protein (CRP, MD = −1.81, 95% CI: −3.32 to −0.29, ), and erythrocyte sedimentation rate (ESR, MD = −3.03, 95% CI: −5.80 to −0.26, ), while compared to control group. Laser acupuncture could reduce HAQ (MD = −0.15, 95% CI: −0.28 to −0.01, ), the RA quality of life questionnaire (RAQoL, MD = −2.32, 95% CI: −4.40 to −0.25, ), CRP (MD = −35.24, 95% CI: −36.49 to −33.99, ), and interleukin-6 (IL-6, MD = −29.63, 95% CI: −49.34 to −9.92, ), while compared to control group. No adverse events associated with acupuncture were reported. Conclusion. Available evidence suggests that acupuncture is beneficial for relieving pain and ameliorating quality of life and health index in patients with RA; thereby, it should be available as an adjunctive nonpharmacological treatment in rehabilitation programmes.
- Open Access
- 18 January 2022
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 24 (1) , e29703
Adherence, Efficacy, and Safety of Wearable Technology–Assisted Combined Home-Based Exercise in Chinese Patients With Ankylosing Spondylitis: Randomized Pilot Controlled Clinical Trial
Background: Clinical practice guidelines recommend that exercise is essential in the self-management of ankylosing spondylitis (AS). Attending supervised interventions requiring periodic medical center visits can be difficult and patients may decline participation, whereas effective home-based exercise interventions that do not require regular medical center visits are likely to be more accessible for AS patients. Objective: The goal of the research was to investigate the adherence, efficacy, and safety of a wearable technology–assisted combined home-based exercise program in AS. Methods: This was a 16-week investigator-initiated, assessor-blinded, randomized, pilot controlled trial conducted at Chinese People’s Liberation Army General Hospital. We enrolled patients with AS who had no regular exercise habits and had been stable in drug treatment for the preceding month. Patients were randomly assigned (1:1) using a computer algorithm. An exercise program consisting of moderate-intensity aerobic exercise and functional exercise was given to the patients in the intervention group. The exercise intensity was controlled by a Mio FUSE Heart Rate Monitor wristband, which uses photoplethysmography to measure heart rate. Patients in the control group received usual care. The primary outcome was the difference in the Ankylosing Spondylitis Disease Activity Score (ASDAS). The secondary outcomes were patient global assessment (PGA), physician global assessment (PhGA), total pain, nocturnal pain, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), BAS Functional Index (BASFI), BAS Metrology Index (BASMI), Spondyloarthritis International Society Health Index (ASAS HI), 36-item Short Form Survey (SF-36), maximal oxygen uptake (VO2) max, body composition, range of motion of joints, and muscle endurance tests. Retention rate, adherence rate, barriers to being active, and adverse events were also assessed. Results: A total of 77 patients were screened, of whom 55 (71%) patients were enrolled; 2% (1/55) withdrew without treatment after randomization. Patients were assigned to the intervention (n=26) or control group (n=28). The median adherence rate of the prescribed exercise protocol was 84.2% (IQR 48.7%-97.9%). For the primary outcome, between-group difference of ASDAS was significant, favoring the intervention (–0.2, 95% CI –0.4 to 0.02, P=.03). For the secondary outcomes, significant between-group differences at 16 weeks were detected in PGA, PhGA, total pain, BASDAI, BASDAI-fatigue, BASDAI–spinal pain, BASDAI–morning stiffness intensity, BASFI, and BASMI. Moreover, the frequency of difficulty in ASAS HI-motivation at 16 weeks was less in the intervention group (P=.03). Between-group difference for change from baseline were also detected in VO2 max, SF-36, back extensor endurance test, and the range of motion of cervical lateral flexion at 16 weeks. Lack of time, energy, and willpower were the most distinct barriers to being active. Incidences of adverse events were similar between groups (P=.11). Conclusions: Our pilot study suggests that this technology-assisted combined home-based exercise program can improve the clinical outcomes of patients with AS who have no exercise habit, with good adherence and safety profile. Trial Registration: Chinese Clinical Trial Registry ChiCTR1900024244; http://www.chictr.org.cn/showproj.aspx?proj=40176
- 18 January 2022
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 24 (1) , e29703
Open AccessAdherence, Efficacy, and Safety of Wearable Technology–Assisted Combined Home-Based Exercise in Chinese Patients With Ankylosing Spondylitis: Randomized Pilot Controlled Clinical Trial
Background: Clinical practice guidelines recommend that exercise is essential in the self-management of ankylosing spondylitis (AS). Attending supervised interventions requiring periodic medical center visits can be difficult and patients may decline participation, whereas effective home-based exercise interventions that do not require regular medical center visits are likely to be more accessible for AS patients. Objective: The goal of the research was to investigate the adherence, efficacy, and safety of a wearable technology–assisted combined home-based exercise program in AS. Methods: This was a 16-week investigator-initiated, assessor-blinded, randomized, pilot controlled trial conducted at Chinese People’s Liberation Army General Hospital. We enrolled patients with AS who had no regular exercise habits and had been stable in drug treatment for the preceding month. Patients were randomly assigned (1:1) using a computer algorithm. An exercise program consisting of moderate-intensity aerobic exercise and functional exercise was given to the patients in the intervention group. The exercise intensity was controlled by a Mio FUSE Heart Rate Monitor wristband, which uses photoplethysmography to measure heart rate. Patients in the control group received usual care. The primary outcome was the difference in the Ankylosing Spondylitis Disease Activity Score (ASDAS). The secondary outcomes were patient global assessment (PGA), physician global assessment (PhGA), total pain, nocturnal pain, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), BAS Functional Index (BASFI), BAS Metrology Index (BASMI), Spondyloarthritis International Society Health Index (ASAS HI), 36-item Short Form Survey (SF-36), maximal oxygen uptake (VO2) max, body composition, range of motion of joints, and muscle endurance tests. Retention rate, adherence rate, barriers to being active, and adverse events were also assessed. Results: A total of 77 patients were screened, of whom 55 (71%) patients were enrolled; 2% (1/55) withdrew without treatment after randomization. Patients were assigned to the intervention (n=26) or control group (n=28). The median adherence rate of the prescribed exercise protocol was 84.2% (IQR 48.7%-97.9%). For the primary outcome, between-group difference of ASDAS was significant, favoring the intervention (–0.2, 95% CI –0.4 to 0.02, P=.03). For the secondary outcomes, significant between-group differences at 16 weeks were detected in PGA, PhGA, total pain, BASDAI, BASDAI-fatigue, BASDAI–spinal pain, BASDAI–morning stiffness intensity, BASFI, and BASMI. Moreover, the frequency of difficulty in ASAS HI-motivation at 16 weeks was less in the intervention group (P=.03). Between-group difference for change from baseline were also detected in VO2 max, SF-36, back extensor endurance test, and the range of motion of cervical lateral flexion at 16 weeks. Lack of time, energy, and willpower were the most distinct barriers to being active. Incidences of adverse events were similar between groups (P=.11). Conclusions: Our pilot study suggests that this technology-assisted combined home-based exercise program can improve the clinical outcomes of patients with AS who have no exercise habit, with good adherence and safety profile. Trial Registration: Chinese Clinical Trial Registry ChiCTR1900024244; http://www.chictr.org.cn/showproj.aspx?proj=40176
- Open Access
- 17 April 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Adherence, Efficacy, and Safety of Wearable Technology–Assisted Combined Home-Based Exercise in Chinese Patients With Ankylosing Spondylitis: Randomized Pilot Controlled Clinical Trial (Preprint)
BACKGROUND Clinical practice guidelines recommend that exercise is essential in the self-management of ankylosing spondylitis (AS). Attending supervised interventions requiring periodic medical center visits can be difficult and patients may decline participation, whereas effective home-based exercise interventions that do not require regular medical center visits are likely to be more accessible for AS patients. OBJECTIVE The goal of the research was to investigate the adherence, efficacy, and safety of a wearable technology–assisted combined home-based exercise program in AS. METHODS This was a 16-week investigator-initiated, assessor-blinded, randomized, pilot controlled trial conducted at Chinese People’s Liberation Army General Hospital. We enrolled patients with AS who had no regular exercise habits and had been stable in drug treatment for the preceding month. Patients were randomly assigned (1:1) using a computer algorithm. An exercise program consisting of moderate-intensity aerobic exercise and functional exercise was given to the patients in the intervention group. The exercise intensity was controlled by a Mio FUSE Heart Rate Monitor wristband, which uses photoplethysmography to measure heart rate. Patients in the control group received usual care. The primary outcome was the difference in the Ankylosing Spondylitis Disease Activity Score (ASDAS). The secondary outcomes were patient global assessment (PGA), physician global assessment (PhGA), total pain, nocturnal pain, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), BAS Functional Index (BASFI), BAS Metrology Index (BASMI), Spondyloarthritis International Society Health Index (ASAS HI), 36-item Short Form Survey (SF-36), maximal oxygen uptake (VO2) max, body composition, range of motion of joints, and muscle endurance tests. Retention rate, adherence rate, barriers to being active, and adverse events were also assessed. RESULTS A total of 77 patients were screened, of whom 55 (71%) patients were enrolled; 2% (1/55) withdrew without treatment after randomization. Patients were assigned to the intervention (n=26) or control group (n=28). The median adherence rate of the prescribed exercise protocol was 84.2% (IQR 48.7%-97.9%). For the primary outcome, between-group difference of ASDAS was significant, favoring the intervention (–0.2, 95% CI –0.4 to 0.02, P=.03). For the secondary outcomes, significant between-group differences at 16 weeks were detected in PGA, PhGA, total pain, BASDAI, BASDAI-fatigue, BASDAI–spinal pain, BASDAI–morning stiffness intensity, BASFI, and BASMI. Moreover, the frequency of difficulty in ASAS HI-motivation at 16 weeks was less in the intervention group (P=.03). Between-group difference for change from baseline were also detected in VO2 max, SF-36, back extensor endurance test, and the range of motion of cervical lateral flexion at 16 weeks. Lack of time, energy, and willpower were the most distinct barriers to being active. Incidences of adverse events were similar between groups (P=.11). CONCLUSIONS Our pilot study suggests that this technology-assisted combined home-based exercise program can improve the clinical outcomes of patients with AS who have no exercise habit, with good adherence and safety profile. CLINICALTRIAL Chinese Clinical Trial Registry ChiCTR1900024244; http://www.chictr.org.cn/showproj.aspx?proj=40176
- 17 April 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessAdherence, Efficacy, and Safety of Wearable Technology–Assisted Combined Home-Based Exercise in Chinese Patients With Ankylosing Spondylitis: Randomized Pilot Controlled Clinical Trial (Preprint)
BACKGROUND Clinical practice guidelines recommend that exercise is essential in the self-management of ankylosing spondylitis (AS). Attending supervised interventions requiring periodic medical center visits can be difficult and patients may decline participation, whereas effective home-based exercise interventions that do not require regular medical center visits are likely to be more accessible for AS patients. OBJECTIVE The goal of the research was to investigate the adherence, efficacy, and safety of a wearable technology–assisted combined home-based exercise program in AS. METHODS This was a 16-week investigator-initiated, assessor-blinded, randomized, pilot controlled trial conducted at Chinese People’s Liberation Army General Hospital. We enrolled patients with AS who had no regular exercise habits and had been stable in drug treatment for the preceding month. Patients were randomly assigned (1:1) using a computer algorithm. An exercise program consisting of moderate-intensity aerobic exercise and functional exercise was given to the patients in the intervention group. The exercise intensity was controlled by a Mio FUSE Heart Rate Monitor wristband, which uses photoplethysmography to measure heart rate. Patients in the control group received usual care. The primary outcome was the difference in the Ankylosing Spondylitis Disease Activity Score (ASDAS). The secondary outcomes were patient global assessment (PGA), physician global assessment (PhGA), total pain, nocturnal pain, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), BAS Functional Index (BASFI), BAS Metrology Index (BASMI), Spondyloarthritis International Society Health Index (ASAS HI), 36-item Short Form Survey (SF-36), maximal oxygen uptake (VO2) max, body composition, range of motion of joints, and muscle endurance tests. Retention rate, adherence rate, barriers to being active, and adverse events were also assessed. RESULTS A total of 77 patients were screened, of whom 55 (71%) patients were enrolled; 2% (1/55) withdrew without treatment after randomization. Patients were assigned to the intervention (n=26) or control group (n=28). The median adherence rate of the prescribed exercise protocol was 84.2% (IQR 48.7%-97.9%). For the primary outcome, between-group difference of ASDAS was significant, favoring the intervention (–0.2, 95% CI –0.4 to 0.02, P=.03). For the secondary outcomes, significant between-group differences at 16 weeks were detected in PGA, PhGA, total pain, BASDAI, BASDAI-fatigue, BASDAI–spinal pain, BASDAI–morning stiffness intensity, BASFI, and BASMI. Moreover, the frequency of difficulty in ASAS HI-motivation at 16 weeks was less in the intervention group (P=.03). Between-group difference for change from baseline were also detected in VO2 max, SF-36, back extensor endurance test, and the range of motion of cervical lateral flexion at 16 weeks. Lack of time, energy, and willpower were the most distinct barriers to being active. Incidences of adverse events were similar between groups (P=.11). CONCLUSIONS Our pilot study suggests that this technology-assisted combined home-based exercise program can improve the clinical outcomes of patients with AS who have no exercise habit, with good adherence and safety profile. CLINICALTRIAL Chinese Clinical Trial Registry ChiCTR1900024244; http://www.chictr.org.cn/showproj.aspx?proj=40176